Frequency Therapeutics Raises $62M in Venture Capital
- Posted by ISPE Boston
- On August 26, 2019
Woburn biotech Frequency Therapeutics has announced the closing of a $62 million Series C financing. Frequency will use the proceeds to support the clinical development of FX-322, a regenerative therapeutic for the treatment of sensorineural hearing loss that is moving into a Phase 2a study, and to advance discovery programs in other therapeutic areas using […]
Read More